{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T20:56:38Z","timestamp":1757451398106,"version":"3.41.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Adnan Menderes University Scientific Research Projects Unit","award":["TPF-14044"],"award-info":[{"award-number":["TPF-14044"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology Biochemistry and Behavior"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.pbb.2015.09.016","type":"journal-article","created":{"date-parts":[[2015,9,26]],"date-time":"2015-09-26T05:08:24Z","timestamp":1443244104000},"page":"91-95","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Antidepressant-like effects of the xanthine oxidase enzyme inhibitor allopurinol in rats. A comparison with fluoxetine"],"prefix":"10.1016","volume":"138","author":[{"given":"B\u00f6rte","family":"G\u00fcrb\u00fcz \u00d6zg\u00fcr","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hatice","family":"Aksu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustafa","family":"Birincio\u011flu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Turhan","family":"Dost","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pbb.2015.09.016_bb0005","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1042\/bj1330585","article-title":"The mechanism of inhibition of rat liver tryptophan pyrrolase activity by 4-hydroxypyrazolo(3,4-d)pyrimidine (allopurinol)","volume":"133","author":"Badawy","year":"1973","journal-title":"Biochem. J."},{"key":"10.1016\/j.pbb.2015.09.016_bb0010","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1139\/o67-197","article-title":"The inhibition of tryptophan pyrrolase by allopurinol, an inhibitor of xanthine oxidase","volume":"45","author":"Becking","year":"1967","journal-title":"Can. J. Biochem."},{"key":"10.1016\/j.pbb.2015.09.016_bb0015","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.psychres.2015.03.031","article-title":"The role of the kynurenine pathway in suicidality in adolescent major depressive disorder","volume":"227","author":"Bradley","year":"2015","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.pbb.2015.09.016_bb0020","first-page":"3796","article-title":"Stimulation of malignant growth in rodents by antidepressant drugs at clinically relevant doses","volume":"52","author":"Brandes","year":"1992","journal-title":"Cancer Res."},{"key":"10.1016\/j.pbb.2015.09.016_bb0025","series-title":"The Role of Serotonin in Psychiatric Disorders","first-page":"91","article-title":"The monoamine hypothesis of depression: the case for serotonin","author":"Brown","year":"1990"},{"key":"10.1016\/j.pbb.2015.09.016_bb0030","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1038\/sj.mp.4000995","article-title":"Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy","volume":"7","author":"Capuron","year":"2002","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.pbb.2015.09.016_bb0035","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/jlb.45.1.29","article-title":"Interferon-induced indoleamine 2,3-dioxygenase activity in human mononuclear phagocytes","volume":"45","author":"Carlin","year":"1989","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.pbb.2015.09.016_bb0040","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0165-6147(02)02017-5","article-title":"Assessing antidepressant activity in rodents: recent developments and future needs","volume":"23","author":"Cryan","year":"2002","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.pbb.2015.09.016_bb0045","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/BF02245592","article-title":"Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants","volume":"121","author":"Detke","year":"1995","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2015.09.016_bb0050","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.schres.2008.12.028","article-title":"A double-blind trial of adjunctive allopurinol for schizophrenia","volume":"109","author":"Dickerson","year":"2009","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.pbb.2015.09.016_bb0055","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1111\/j.1469-7610.2010.02245.x","article-title":"The possible role of the kynurenine pathway in adolescent depression with melancholic features","volume":"51","author":"Gabbay","year":"2010","journal-title":"J. Child Psychol. Psychiatry"},{"key":"10.1016\/j.pbb.2015.09.016_bb0060","article-title":"Inhibition of stress-induced hepatic tryptophan 2,3-dioxygenase exhibits antidepressant activity in an animal model of depressive behaviour","volume":"1-12","author":"Gibney","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.pbb.2015.09.016_bb0065","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/0006-2952(75)90248-8","article-title":"Effects of hydrocortisone and immobilization on tryptophan metabolism in brain and liver of rats of different ages","volume":"24","author":"Green","year":"1975","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.pbb.2015.09.016_bb0070","first-page":"220","article-title":"Fluoxetine-induced reduction of body mass in patients with major depressive disorder","volume":"24","author":"Harto","year":"1988","journal-title":"Psychopharmacol. Bull."},{"key":"10.1016\/j.pbb.2015.09.016_bb0075","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0022-3565(24)36841-7","article-title":"Potential antidepressant effects of novel tropane compounds, selective for serotonin or dopamine transporters","volume":"282","author":"Hemby","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pbb.2015.09.016_bb0080","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/hup.742","article-title":"Nitric oxide, adenosine deaminase, xanthine oxidase and superoxide dismutase in patients with panic disorder: alterations by antidepressant treatment","volume":"21","author":"Herken","year":"2006","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.pbb.2015.09.016_bb0085","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.arcmed.2006.10.005","article-title":"Adenosine deaminase, nitric oxide, superoxide dismutase, and xanthine oxidase in patients with major depression: impact of antidepressant treatment","volume":"38","author":"Herken","year":"2007","journal-title":"Arch. Med. Res."},{"year":"2011","series-title":"IBM SPSS Statistics for Windows","author":"IBM C","key":"10.1016\/j.pbb.2015.09.016_bb0090"},{"key":"10.1016\/j.pbb.2015.09.016_bb0095","doi-asserted-by":"crossref","first-page":"244","DOI":"10.4103\/0253-7613.111922","article-title":"Evaluation of effect of allopurinol and febuxostat in behavioral model of depression in mice","volume":"45","author":"Karve","year":"2013","journal-title":"Indian J. Pharm."},{"key":"10.1016\/j.pbb.2015.09.016_bb0100","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1756-6606-3-8","article-title":"Depression research: where are we now?","volume":"3","author":"Lee","year":"2010","journal-title":"Mol. Brain"},{"key":"10.1016\/j.pbb.2015.09.016_bb0105","doi-asserted-by":"crossref","first-page":"275","DOI":"10.2174\/1566524015666150330163724","article-title":"Purinergic signaling and energy homeostasis in psychiatric disorders","volume":"15","author":"Lindberg","year":"2015","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.pbb.2015.09.016_bb0110","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/00008877-199711000-00010","article-title":"The forced swimming test as a model for core and component behavioral effects of antidepressant drugs","volume":"8","author":"Lucki","year":"1997","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.pbb.2015.09.016_bb0115","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.4088\/JCP.v69n0806","article-title":"A double-blind, randomized, placebo-controlled 4-week study on the efficacy and safety of the purinergic agents allopurinol and dipyridamole adjunctive to lithium in acute bipolar mania","volume":"69","author":"Machado-Vieira","year":"2008","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.pbb.2015.09.016_bb0120","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/sj.mp.4000872","article-title":"Treatment with interferon-alpha (IFN alpha) of hepatitis C patients induces lower serum dipeptidyl peptidase IV activity, which is related to IFN alpha-induced depressive and anxiety symptoms and immune activation","volume":"6","author":"Maes","year":"2001","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.pbb.2015.09.016_bb0125","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.pnpbp.2010.12.017","volume":"35","author":"Maes","year":"2011","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pbb.2015.09.016_bb0130","first-page":"361","article-title":"The effect of the 5-HT re-uptake inhibitor fluoxetine on food intake and body weight in healthy male subjects","volume":"14","author":"McGuirk","year":"1990","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.pbb.2015.09.016_bb0135","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.pnpbp.2013.08.008","article-title":"Network beyond IDO in psychiatric disorders: revisiting neurodegeneration hypothesis","volume":"48","author":"Myint","year":"2014","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pbb.2015.09.016_bb0140","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/266730a0","article-title":"Depression: a new animal model sensitive to antidepressant treatments","volume":"266","author":"Porsolt","year":"1977","journal-title":"Nature"},{"key":"10.1016\/j.pbb.2015.09.016_bb0145","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0014-2999(78)90118-8","article-title":"Behavioural despair in rats: a new model sensitive to antidepressant treatments","volume":"47","author":"Porsolt","year":"1978","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pbb.2015.09.016_bb0150","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/s002130050555","article-title":"Antidepressant behavioral effects by dual inhibition of monoamine reuptake in the rat forced swimming test","volume":"136","author":"Reneric","year":"1998","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2015.09.016_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpsychires.2015.05.007","article-title":"Kynurenine pathway dysfunction in the pathophysiology and treatment of depression: evidences from animal and human studies","author":"Reus","year":"2015","journal-title":"J. Psychiatr. Res"},{"key":"10.1016\/j.pbb.2015.09.016_bb0160","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/B978-0-12-801022-8.00016-7","article-title":"The adenosine neuromodulation system in schizophrenia","volume":"119","author":"Rial","year":"2014","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.pbb.2015.09.016_bb0165","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.bbi.2015.02.007","article-title":"Reduction of kynurenic acid to quinolinic acid ratio in both the depressed and remitted phases of major depressive disorder","volume":"46","author":"Savitz","year":"2015","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.pbb.2015.09.016_bb0170","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1476-5381.2008.00025.x","article-title":"Anti-nociceptive properties of the xanthine oxidase inhibitor allopurinol in mice: role of A1 adenosine receptors","volume":"156","author":"Schmidt","year":"2009","journal-title":"Br. J. Pharmacol."}],"container-title":["Pharmacology Biochemistry and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305715300678?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305715300678?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T20:34:44Z","timestamp":1748637284000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091305715300678"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":34,"alternative-id":["S0091305715300678"],"URL":"https:\/\/doi.org\/10.1016\/j.pbb.2015.09.016","relation":{},"ISSN":["0091-3057"],"issn-type":[{"type":"print","value":"0091-3057"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antidepressant-like effects of the xanthine oxidase enzyme inhibitor allopurinol in rats. A comparison with fluoxetine","name":"articletitle","label":"Article Title"},{"value":"Pharmacology Biochemistry and Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pbb.2015.09.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}